The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...

SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility ...

LS Securities forecasted on the 22nd that sales of Nextbiomedical will rapidly increase as the market penetration rate of NexPowder rises. Jo Eun-ae, a researcher at LS Securities, explained, ...

Next Biomedical announced on the 17th that it has completed the first shipment of its hemostatic agent for endoscopy, Nexpowder, to Japan. Nexpowder received product approval from the Pharmaceuticals ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared the endoscopic hemostasis system Nexpowder, which is intended to improve visibility and ...

Malignant adhesive bowel obstruction (MABO) 1,2 caused by peritoneal carcinomatosis is a refractory complication of advanced primary abdominal pelvic malignancy or distant metastasis, leading to poor ...